In brief: VGM’s new collab, Kalogon’s funding, Medline’s milestone

WATERLOO, Iowa — VGM & Associates has launched a collaboration with Resmed to help home medical equipment (HME) providers strengthen their sleep therapy programs. By combining VGM’s expanding Total Sleep Services offering with Resmed’s connected sleep health capabilities, the two companies say they create a more connected path from diagnosis to long-term therapy adherence.

The collaboration brings together VGM’s member community and category expertise with Resmed’s health technology portfolio to help providers move patients into therapy faster, improve care coordination and support stronger long-term outcomes. The initiative is focused on reducing fragmentation in the sleep pathway, where delays in testing and inconsistent workflows have limited access to therapy and, ultimately, slowed access to care for patients, the companies say.

VGM & Associates and Resmed commentary

“At VGM, we believe if we do not step forward to help solve this, the system will continue to evolve without providers at the center,” said Lindy Tentinger, president of VGM & Associates. “That is not acceptable. This is our opportunity to lead. Our work with Resmed is about more than a collaboration. It is about reducing friction in how care is delivered so providers can scale and patients can get treatment faster. By aligning with Resmed, we are expanding access to solutions that support member growth, help improve patient outcomes, and remove barriers to care.”

“HMEs are central to how patients access and stay in sleep therapy, and Resmed is committed to supporting their success, said Jeff Haley, vice president of sales, Americas, at Resmed. “VGM brings deep reach into the HME community, and together we’re helping ensure more providers have the innovation and resources they need to help patients succeed on therapy.”

Benefit to HME providers

VGM says as demand grows for home-based diagnostics and more efficient patient engagement, the collaboration reflects a shared commitment to helping providers adapt to a rapidly evolving sleep care landscape.

For HME providers, that means broader access to solutions that can reduce operational bottlenecks, simplify workflows, and improve the experience for patients and referral sources. Through this collaboration, VGM members will gain access to resources that help them build more connected sleep programs that support patient care and engagement.

VGM says the initiative is intended to improve access to diagnosis and long-term therapy support, help reduce testing bottlenecks, and accelerate time to therapy, which supports adherence and continuity of care. Together, it says these solutions help providers address critical needs across the patient care continuum.

Continued support for multi-vendor ecosystem

VGM says it will continue to support a strong multi-vendor ecosystem within the sleep and respiratory category, ensuring providers maintain the flexibility to choose solutions that best meet patient needs.

“At VGM, we believe innovation delivers the greatest value when it reaches patients,” Tentinger said. “Our collaboration with Resmed brings together their innovation and our member community to help remove barriers to care and empower the HME community to do what they do best: care for patients.”

Kalogon secures additional funding, plans to increase hiring

MELBOURNE, Fla. – Kalogon has raised $5.75 million in funding, led by Enable Ventures, a venture fund that says it is dedicated to closing the disability wealth gap. Other investors include Florida Opportunity Fund, Castellan Group and returning investors DeepWork Capital, Sawmill Angels and Black Opal.

Kalogon will use the capital to:

• Hire across engineering, research and business development
• Expand the number of products offered internationally
• Invest in the intelligence that its growing suite of deployed smart cushions makes possible

“People who use wheelchairs face real health consequences from sitting, but the stresses of sitting don't stop there,” said Tim Balz, founder and CEO of Kalogon. “When you solve for the people with the greatest need, you end up solving it for everyone. Our work with the U.S. Air Force showed us that the same technologies that help wheelchair users can help a B-52 pilot endure a 30-hour mission at peak performance. Improving seating has applications everywhere, and this investment lets us chase the full scope of that opportunity.”

Kalogon says the funding comes on the heels of a breakout year for the company, which has more than tripled its medical revenue year-over-year and moved into a dedicated manufacturing facility in Melbourne to meet increasing demand.

The company’s full seating system technology is currently in pilot testing to relieve fatigue and pain for U.S. Air Force aircrew on B-52 and E-4B long-duration missions, with commercial aviation and automotive partnerships in development.

• Related: Kalogon’s production, leadership investments tee up growth

Soleo Health expands mid-Atlantic footprint with acquisition of Realo

FRISCO, Texas, and MORRISVILLE, N.C. – Soleo Health has acquired Realo Specialty Care Pharmacy and BluHaven Management from parent company Realo Drugs, expanding its footprint in the mid-Atlantic region.

Realo Specialty Care’s specialty pharmacy, located in Morrisville, N.C., and BluHaven’s infusion center, located in Raleigh, N.C., complement Soleo Health’s nationwide portfolio of 28 specialty pharmacies and more than 30 ambulatory infusion suites and centers, the company says.

“We welcome Realo Specialty Care and BluHaven to the Soleo Health family,” said Drew Walk, CEO at Soleo Health. “Since their founding in 2015, they established themselves as a leading specialty pharmacy and infusion provider in the region. Their esteemed reputation reflects a best-in-class care model that brings together clinical expertise and care coordination to deliver high-quality support for patients and providers.”

Principals Charlie Frye, PharmD, and Will Holland, PharmD, along with the entire Realo Specialty Care and BluHaven team, will join Soleo Health.

• Related: BluHaven Health meets community’s next need.
• Related: Soleo Health taps new VP of sales.

Medline marks six decades in business

NORTHFIELD, Ill. - Medline celebrates its 60^th anniversary this month. Founded by brothers Jim and Jon Mills, the company began as a modest, family-run operation that manufactured health care apparel for providers in and around Chicago – a natural evolution from the meat-packing aprons, surgical gowns and nurses’ attire that the brothers’ grandfather, A.L. Mills, had started supplying local customers two generations earlier.

Today, the company:

• Distributes approximately 335,000 health care products, including approximately 190,000 under the Medline Brand and about 70,000 of those self-manufactured
• Net sales of more than $28.4 billion in 2025
• 70 global distribution centers
• 30 global manufacturing facilities
• More than 45,000 employees worldwide, including a U.S. commercial team of more than 4,000
• A fleet of 2,100+ MedTrans delivery trucks enabling next-day delivery to 95% of U.S. customers

“The evidence of our impact is unmistakable as we’ve progressed through the years, relentlessly focusing on serving healthcare providers across all points of care, building a massive product portfolio and establishing one of the most robust and resilient supply chains in the industry,” said Doug Golwas, chief commercial officer. “Every moment of every day, as healthcare providers seek to provide the best care for their patients, Medline is right by their side.”

2025: Proudly public

Medline’s initial public offering near the end of 2025 was the largest of the year in the U.S. and the third largest in the last 10 years, raising more than $7 billion to support continued investment in innovation, resiliency and value-driven solutions for Medline customers across all points of care, the company says.

• Related: Medline focuses on mitigation as oil prices, tariffs shift

VGM to name 2026 HME Woman of the Year at Heartland Conference

WATERLOO, Iowa – VGM will name the 2026 HME Woman of the Year at its Heartland Conference in Waterloo, Iowa, on Tuesday, June 9. The finalists for the award are:

• Jeaneen Cole, vice president of quality and compliance, DASCO HME
• Shawna Carlson, director of rehab services, CareLinc Medical Equipment
• Lisa Wells, senior vice president, Med-South, Inc.
• Julie Osborn, president and CEO, Alliance Rehab and Medical Equipment
• Whitney Baker, director of DME operations and integrations, Viemed

Now in its 10th year, the HME Woman of the Year Award recognizes extraordinary leaders who have made significant and lasting contributions to the home medical equipment (HME) industry. Eligible nominees represent a wide range of roles, including providers, manufacturers, association leaders, clinicians, consultants and advocates in HME, complex rehab technology (CRT), respiratory care, women’s health, and related segments. To learn more about the finalists, go here.

Read about past winners: 

•  Tenacity, trailblazing & tech: Robin Menchen’s vision for future of HME. 
• 2023 HME WOY Dana McLaughlin is ‘open for questions’. 

VA reduces wait times for prosthetic limbs

WASHINGTON — The Department of Veterans Affairs says it has reduced wait times for prosthetic limbs by 10 days, after streamlining the purchasing process. The VA expects average wait times to fall more than 40% – from 94 days to 54 days – as facilities across the nation fully implement this new process. “Every day counts for veterans,” said VA Secretary Doug Collins. “By removing needless bureaucracy, VA is enabling clinicians and procurement teams to provide Veterans with high-quality prosthetic care, better and faster than before.” Under prior procurement rules, orders for all prosthetic limbs had to be approved by a contracting officer, which meant veterans had to wait several additional weeks before delivery. On April 22, Collins exempted approximately 95% of prosthetic limb orders from contracting officer reviews and determined that only the most expensive prosthetic limbs would continue to be subject to these reviews. He also authorized local purchasing agents to source directly from local suppliers whenever prosthetic limb prices are set by Medicare, in which case there is no negotiation over price and no need for review by a contracting officer.

HME Medical Distribution co-founders recognized

RICHMOND, B.C. – HME Medical Distribution co-founders Robert Boscacci and Cameron Fleming have been named finalists for the EY Entrepreneur of the Year 2026 Pacific program. HME has grown over the past 14 years from a four-person operation into one of Canada’s largest, independently owned medical equipment distribution and accessibility companies, it says. “As HME has grown, we have always stayed true to our values of innovating products, improving accessibility, and making mobility a strength for the people we serve,” said Boscacci. “Over the past 14 years, HME has evolved from a traditional home medical dealer into a fully integrated medical distribution company with a growing dealer network, proprietary product development initiatives, and Health Canada Class 1, 2 and 3 medical device capabilities.” The EY Entrepreneur of the Year program recognizes entrepreneurs who demonstrate excellence in areas like innovation, financial performance, vision and community impact.

Read about some of HME’s recent growth:

• HME partners with Yuwell, adds respiratory to portfolio
• HME Home Health expands presence in British Columbia 

Glooko, mylife Diabetes Care expand partnership, ensure continuity

GOTEHNBURG, Sweden and BURGDORF, Switzerland – As a result of an expanded partnership Glooko will serve as mylife Diabetes Care’s primary data management platform for mylife products. The companies say this next step ensures continuity in the way health care professionals and patients access data from mylife products, including mylife Loop, an automated insulin delivery (AID) solution powered by mylife CamAPS FX from CamDiab. They say it also strengthens the shared commitment of both companies to support day-to-day clinical practice and improving outcomes. “Diabetes care is increasingly connected, and data management is one of the most important layers in helping people with diabetes and care teams make sense of information across devices and therapies,” said Mike Alvarez, CEO of Glooko. “We’re proud that mylife Diabetes Care has selected Glooko as its preferred data management partner. We’re excited to build on our strong partnership and support a smoother, more connected experience for mylife users and their healthcare teams.” The companies encourage people using mylife’s products who are not yet connected to Glooko to consult their health care professional or contact Glooko for support and onboarding information.